SCHEMBL18857987

SCHEMBL18857987

CC1(C)C2CC3OB(B4OC5CC6CC(C6(C)C)[C@]5(C)O4)O[C@@]3(C)C1C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PREP P48147 11/20 0.40
▸ FAP Q12884 1/20 0.37
▸ PSMB5 P28074 5/20 0.37
▸ PSMB11 A5LHX3 1/20 0.37
▸ PSMD11 O00231 1/20 0.37
▸ PSMD12 O00232 1/20 0.37
▸ PSMD14 O00487 1/20 0.37
▸ PSMA7 O14818 1/20 0.37
▸ PSMD3 O43242 1/20 0.37
▸ PSMC3 P17980 1/20 0.37
▸ PSMB1 P20618 1/20 0.37
▸ PSMA1 P25786 1/20 0.37
▸ PSMA2 P25787 1/20 0.37
▸ PSMA3 P25788 1/20 0.37
▸ PSMA4 P25789 1/20 0.37
▸ PSMB8 P28062 1/20 0.37
▸ PSMB9 P28065 1/20 0.37
▸ PSMA5 P28066 1/20 0.37
▸ PSMB4 P28070 1/20 0.37
▸ PSMB6 P28072 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31087425 1.00 PREP (0.40) PREPFAPPSMB5PSMB11PSMD11
SCHEMBL31298932 1.00 PREP (0.40) PREPFAPPSMB5PSMB11PSMD11
SCHEMBL21911589 1.00 PREP (0.40) PREPFAPPSMB5PSMB11PSMD11
SCHEMBL19889110 1.00 PREP (0.40) PREPFAPPSMB5PSMB11PSMD11
SCHEMBL15867198 1.00 PREP (0.40) PREPFAPPSMB5PSMB11PSMD11
SCHEMBL23451168 1.00 PREP (0.40) PREPFAPPSMB5PSMB11PSMD11
SCHEMBL18867526 0.89 PREP (0.35) PREPFAPPSMB5PSMB11PSMD11
SCHEMBL22017943 0.85 PREP (0.34) PREPFAPPSMB5PSMB11PSMD11
SCHEMBL21911464 0.84 PREP (0.35) PREPFAPPSMB5PSMB11PSMD11
SCHEMBL12980258 0.83 PREP (0.39) PREPFAPPSMB5PSMB11PSMD11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170136047-A1 BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF REMPEX PHARMACEUTICALS, INC. (US) 2017-05-18 — — US disclosed
US-20170136047-A1 BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF REMPEX PHARMACEUTICALS, INC. (US) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170136047-A1 BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF BCL6B, BTD, BCL6 PREP 1020/4885FAP 587/4885PSMB5 4313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback